Ottery F D, Bruskewitz R C, Weese J L
Cancer. 1986 Feb 1;57(3):563-6. doi: 10.1002/1097-0142(19860201)57:3<563::aid-cncr2820570327>3.0.co;2-c.
Transrectal resection of rectal cancers with the use of the urologic resectoscope is a safe, controlled technique that allows good visualization with defined limits of excision. Twenty-three patients have undergone 50 transrectal resections, with a median survival of 10.8 months. Only 1 of 22 patients required subsequent colostomy before death. Patients, followed as long as 29 months, have had good local control of tumor and excellent palliation of symptoms.